ZEROHour Prostate Cancer Newsletter

Breaking Barriers: Black History Month and the Fight Against Prostate Cancer

This Black History Month, we're spotlighting a critical health disparity in our community: Black men face a significantly higher risk of prostate cancer, with one in six developing the disease in their lifetime. While these statistics are sobering—Black men are 2.1 times more likely to die from prostate cancer than white men—ZERO is committed to changing this narrative through awareness, advocacy, and action.

Our Black Men's Prostate Cancer Initiative provides targeted support through educational resources, support groups, and more. We're working to address historical barriers to care, from increasing access to PSA testing to combating racial bias in healthcare delivery. Early detection is key: Black men should begin prostate cancer screening discussions with their doctors by age 40.

Additionally, through ZERO360, our comprehensive support service, we're ensuring that Black men and their families have access to the resources they need for treatment and survival.

Stars Strut for a Cause: NYFW Opens with ZERO's Annual Blue Jacket Fashion Show

Tomorrow, on World Cancer Day, New York Fashion Week kicks off with a powerful statement about men's health. The Ninth Annual Blue Jacket Fashion Show unites celebrities, designers, and advocates in a groundbreaking event to raise awareness for prostate cancer.

Watch stars like Mario Cantone, Don Lemon, and J. Harrison Ghee walk the runway in reimagined blue jackets by renowned designers, including Tommy Hilfiger, Thom Browne, and Michael Kors. This year's show, hosted at LAVAN Midtown, promises to be bigger than ever. The day will also feature free PSA screenings at multiple locations throughout NYC.

Join us virtually through our live stream at zerocancer.org and be part of this vital conversation about men's health. With Johnson & Johnson matching donations up to $10,000 through March 1, your contribution will help create a future where no family faces prostate cancer alone.

Cancer Statistics 2025: Understanding the Numbers

The American Cancer Society released its annual cancer statistics, projecting 313,780 new prostate cancer cases and 35,770 deaths in 2025. While these numbers are sobering, the data has both challenge and hope.

Prostate cancer remains the most common cancer diagnosis in men, accounting for 30% of all male cancer cases. After years of decline, incidence rates have risen by 3% annually since 2014, driven by larger increases in advanced-stage diagnoses.

However, improved screening strategies, including MRI-integrated testing and genetic screening, are helping detect aggressive cancers earlier while reducing unnecessary biopsies. The five-year survival rate for prostate cancer now stands at 97%, among the highest for all cancers.

These numbers underscore the critical importance of informed screening decisions and equitable access to care, particularly for Black men, who face higher risks and may benefit from earlier testing starting at age 40.

Vegas Welcomes ZERO Support Group Leaders and MENtors in 2025

This August 1-2, The Paris Hotel & Casino in Las Vegas will host ZERO's annual Support Group Leader and MENtor Training, bringing together dedicated volunteers who facilitate our vital prostate cancer support communities nationwide.

This transformative two-day event offers Support Group Leaders and MENtors unique opportunities for peer-to-peer learning, strategy sharing, and enhancing their support skills. Participants will connect with fellow leaders and MENtors while gaining valuable insights to strengthen their local support communities. ZERO is committed to making this experience accessible by providing hotel accommodations for attendees.

Can't attend personally? Consider sending a representative from your support group. This invaluable training strengthens our entire support network and empowers both Support Group Leaders and MENtors to better serve their communities. Stay tuned for details about travel stipends and the full agenda.

CDMRP Become a Voice for Prostate Cancer Research Are you a prostate cancer patient or survivor? Interested in contributing to cutting-edge prostate cancer research? Consider joining the Prostate Cancer Research Program's Consumer Reviewer Program. As a Consumer Reviewer, you'll bring your valuable lived experience to help evaluate research grant proposals and ensure meaningful impact on patients' lives.» Learn More About CDMRP

Post-ASCO GU Webinar Breaking Down the Latest in Prostate Cancer Research: Post ASCO GU Webinar Don't miss this exclusive opportunity to hear about the latest breakthroughs in prostate cancer treatment! Dr. Yaw Nyame will discuss the most significant findings from the 2025 Genitourinary (GU) Cancers Symposium. Mark your calendar for March 12 at 5:00 p.m. ET and join us for this important virtual update.» Register Now

Digest Never Miss a Breakthrough: Subscribe to Discoveries Digest Want to understand the latest breakthroughs in prostate cancer research? Our monthly Prostate Cancer Discoveries Digest delivers easy-to-understand summaries of groundbreaking studies and medical advances to your inbox. Follow along for developments shaping prostate cancer care, from new treatments to survivorship insights.» Subscribe Today

Newsletter Your Guide to Advanced Prostate Cancer in 2025 Stay informed about what matters most to the advanced prostate cancer community. Our annual newsletter compiles essential updates on treatment advances, support resources, and community events specifically for those affected by advanced/metastatic prostate cancer. Access our 2024 Advanced Prostate Cancer Newsletter right now and be on the lookout for our highly anticipated 2025 edition, available February 13th.» Bookmark Advanced Prostate Cancer Newsletter